-
radiopharmaceutical platforms that can improve cancer detection, patient selection, treatment delivery, and therapeutic response. Our research combines radiochemistry, chemical biology, antibody engineering, host–guest
-
of the Rockies (NLR, formerly NREL) provide for an exceptionally inspiring research environment. At the University of Colorado our group is affiliated with the Materials Science and Engineering Program, the Center
-
. The main research of the lab focuses on engineering novel unconventional immune cell subsets to enhance tumor immunity. Dr. Tobin's lab has several exciting research projects with the potential of clinical
-
any of the following: Molecular Biology Expression and purification of recombinant proteins Membrane protein production and characterization Protein engineering and biochemical assay development
-
dissection. · Experience with the characterization and phenotyping of genetically engineered or experimentally induced mouse models. · Experience with skeletal muscle phenotyping, including
-
environment for trainees to thrive and pursue their career goals. DBMI has a dedicated team for Grants Development and Scientific Writing, and a Software Engineering Team that can provide invaluable feedback
-
-generation sequencing–based methods and multi-omics data integration Proficiency in genome engineering techniques (e.g., CRISPR/Cas systems) Experience working with cancer models, particularly brain cancer